ZERINI, DARIO
ZERINI, DARIO
Universita' degli Studi di MILANO
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison
2022 R. Cambria, D. Ciardo, A. Bazani, F. Pansini, E. Rondi, D. Maestri, D. Zerini, G. Marvaso, P. Romanelli, G. Timon, C. Fodor, G. Petralia, S. Alessi, P. Pricolo, B. Vischioni, P. Fossati, S. Molinelli, S. Russo, M. Ciocca, O. De Cobelli, G. Renne, R. Orecchia, F. Cattani, B.A. Jereczek-Fossa
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis
2022 G. Corrao, G. Marvaso, M. Zaffaroni, S. Volpe, M. Augugliaro, C.I. Fodor, D. Zerini, A. Vingiani, F.A. Mistretta, S. Luzzago, S. Alessi, P. Pricolo, G. Musi, O. De Cobelli, G. Renne, M. Manzoni, G. Petralia, R. Orecchia, B.A. Jereczek-Fossa
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218)
2021 S.G. Gugliandolo, M. Pepa, L.J. Isaksson, G. Marvaso, S. Raimondi, F. Botta, S. Gandini, D. Ciardo, S. Volpe, G. Riva, D.P. Rojas, D. Zerini, P. Pricolo, S. Alessi, G. Petralia, P.E. Summers, F.A. Mistretta, S. Luzzago, F. Cattani, O. De Cobelli, E. Cassano, M. Cremonesi, M. Bellomi, R. Orecchia, B.A. Jereczek-Fossa
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis
2021 G. Corrao, G. Marvaso, M. Zaffaroni, C.I. Fodor, S. Volpe, L. Bergamaschi, D. Zerini, A. Vingiani, G. Petralia, S. Alessi, P. Pricolo, G. Renne, R. Orecchia, B.A. Jereczek-Fossa
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience
2021 M. Augugliaro, G. Marvaso, R. Cambria, M. Pepa, V. Bagnardi, S. Frassoni, F. Pansini, D. Patricia Rojas, F. Colombo, C. Iuliana Fodor, G. Musi, G. Petralia, O. De Cobelli, F. Cattani, R. Orecchia, D. Zerini, B. Alicja Jereczek-Fossa
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
2021 B.A. Jereczek-Fossa, G. Marvaso, M. Zaffaroni, S.G. Gugliandolo, D. Zerini, F. Corso, S. Gandini, F. Alongi, A. Bossi, P. Cornford, B. De Bari, V. Fonteyne, P. Hoskin, B.R. Pieters, A.C. Tree, S. Arcangeli, D.B. Fuller, C. Franzese, J.-. Hannoun-Levi, G. Janoray, L. Kerkmeijer, Y. Kwok, L. Livi, M. Loi, R. Miralbell, D. Pasquier, M. Pinkawa, N. Scher, M. Scorsetti, M. Shelan, A. Toledano, N. van As, A. Vavassori, T. Zilli, M. Pepa, P. Ost
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
2021 G. Marvaso, B. Vischioni, M. Pepa, M. Zaffaroni, S. Volpe, F. Patti, F. Bellerba, S. Gandini, S. Comi, G. Corrao, D. Zerini, M. Augugliaro, C. Fodor, S. Russo, S. Molinelli, M. Ciocca, R. Ricotti, F. Valvo, T. Giandini, B. Avuzzi, R. Valdagni, O. De Cobelli, F. Cattani, E. Orlandi, B.A. Jereczek-Fossa, R. Orecchia
Oligo metastatic renal cell carcinoma : stereotactic body radiation therapy, if, when and how?
2021 G. Marvaso, G. Corrao, O. Oneta, M. Pepa, M. Zaffaroni, F. Corso, S. Gandini, A. Cecconi, D. Zerini, G.C. Mazzola, M. Augugliaro, M. Cossu Rocca, E. Verri, F. Cattani, F. La Fauci, L. Bergamaschi, S. Luzzago, A.F. Mistretta, G. Musi, F. Nole, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom?
2020 G. Marvaso, M. Montesano, G. Corrao, S.P. De Angelis, S. Gandini, G.C. Mazzola, M. Augugliaro, J. Franzetti, D. Zerini, M. Pepa, S. Luzzago, F.A. Mistretta, G. Musi, F. Nole, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
Erratum: Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation (La Radiologia medica (2019) 124 1 (65-78))
2020 B.A. Jereczek-Fossa, A. Surgo, P. Maisonneuve, A. Maucieri, M.A. Gerardi, D. Zerini, G. Marvaso, D. Ciardo, S. Volpe, D.P. Rojas, G. Riva, O. Alessandro, S. Dicuonzo, G. Fanetti, P. Romanelli, A. Starzynska, F. Cattani, R. Cambria, C. Fodor, C. Garibaldi, C. Romano, O. De Cobelli, R. Orecchia
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation : results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2020 D. Zerini, B.A. Jereczek-Fossa, A. Ciabattoni, A. Mirri, F. Bertoni, S. Fersino, G. D’Agostino, F. Lohr, G. Mortellaro, L. Triggiani, G. Marvaso, M. Pepa, F. Cuccia, F. Alongi
Mixed-beam approach for high-risk prostate cancer : Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300)
2020 S.G. Gugliandolo, G. Marvaso, S. Comi, M. Pepa, C. Romano, D. Zerini, M. Augugliaro, S. Russo, B. Vischioni, F. Valvo, T. Giandini, B. Avuzzi, R. Valdagni, D. Ciardo, O. De Cobelli, B.A. Jereczek-Fossa, F. Cattani, R. Orecchia
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218)
2020 G. Marvaso, S.G. Gugliandolo, F. Bellerba, S. Gandini, G. Corrao, S. Volpe, D.P. Rojas, G. Riva, D. Zerini, M. Pepa, C.I. Fodor, E. La Rocca, P. Pricolo, S. Alessi, G. Petralia, F.A. Mistretta, R. Cambria, F. Cattani, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159)
2019 G. Marvaso, D. Ciardo, G. Corrao, S. Gandini, C. Fodor, D. Zerini, D.P. Rojas, M. Augugliaro, G. Bonizzi, S. Pece, F. Cattani, K. Mazzocco, F.A. Mistretta, G. Musi, S. Alessi, G. Petralia, G. Pravettoni, O. De Cobelli, P.P. Di Fiore, G. Viale, R. Orecchia, B.A. Jereczek-Fossa
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer : A Propensity Score Analysis
2019 G. Marvaso, D. Ciardo, S. Gandini, G. Riva, E. Frigo, S. Volpe, C. Fodor, D. Zerini, D.P. Rojas, S. Comi, R. Cambria, F. Cattani, G. Musi, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach
2018 G. Marvaso, G. Riva, D. Ciardo, S. Gandini, C. Fodor, D. Zerini, S.P. Colangione, G. Timon, S. Comi, R. Cambria, F. Cattani, O. De Cobelli, R. Orecchia, B.A. Jereczek
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases
2018 G. Fanetti, G. Marvaso, D. Ciardo, A. Rese, R. Ricotti, E. Rondi, S. Comi, F. Cattani, D. Zerini, C. Fodor, O. de Cobelli, R. Orecchia, A. Jereczek Barbara
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome
2017 G. Riva, G. Marvaso, M. Augugliaro, D. Zerini, C. Fodor, G. Musi, O. De Cobelli, R. Orecchia, B.A. Jereczek-Fossa
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy
2014 B.A. Jereczek-Fossa, M. Rodari, M. Bonora, P. Fanti, C. Fodor, G. Pepe, E. Lopci, D. Zerini, B. Vischioni, G. Baroni, D.V. Matei, O. De Cobelli, A. Chiti, R. Orecchia